If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Board Appointments

27 Jun 2022 07:00

RNS Number : 2052Q
Allied Minds PLC
27 June 2022
 

27 June 2022

Allied Minds plc

("Allied Minds" or the "Company")

Board Appointments

 

Allied Minds plc (LSE: ALM), the IP commercialisation company focused on early-stage company development within the technology sector, announces the appointment of Sam Dobbyn and Casey McDonald as non-executive directors of the Company. Both appointments are effective immediately.

 

Sam Dobbyn is a UK-based corporate executive with deep public markets experience and a proven record of optimising shareholder returns. Until March 2022, he was CEO and previously CFO of Urban Exposure PLC where he reduced the cost base, managed a sale process and ultimately delivered a successful delisting of the business. He was previously Head of Financial Planning and Analysis and Head of Investor Relations at both TP ICAP PLC and Brit PLC. Mr. Dobbyn is a qualified Chartered Accountant and has an Executive MBA from Warwick & Guanghua Business School. 

 

Casey McDonald is a corporate governance and regulatory expert with over 25 years' experience of serving on boards and other fiduciary appointments. He is an independent director at fund governance firm Calderwood Management Ltd, where he leads the Special Situations practice. Prior to this, he served as Managing Director of a boutique insolvency firm and spent 15 years with KPMG, including leading its advisory practice in the British Virgin Islands. Mr. McDonald holds a Bachelor of Business Administration and is a member of both the Canadian Institute of Chartered Accountants and the Cayman Islands Institute of Professional Accountants.

 

The appointments restore the appropriate number of non-executive directors to the board.

 

Bruce Failing, Interim Chairman of Allied Minds, commented:

 

"I am pleased to welcome Sam and Casey to the board of Allied Minds. Both directors have complementary expertise of managing special situations and maximising returns for shareholders. Their skillset will add valuable insight as we pursue the options outlined in our Strategic Review."

 

The below disclosures are made as required under paragraph 9.6.13R of the Listing Rules.

 

The following companies were placed into liquidation or receivership/administration where Mr. Dobbyns was a director at the time or within the 12 months preceding such event:

Urban Exposure PLC: Sam Dobbyns was appointed in July 2019 and resigned in June 2021. The company was put into a members' voluntary liquidation in June 2021 after a successful run-off of the assets of the company (and its subsidiaries: Urban Exposure Finance PLC, Urban Exposure Holdings Limited, Urban Exposure AMCO Limited, Urban Exposure Lendco Limited, UE SFA 1 Limited).LW UE (Davies Street) Limited: The company did not trade and was dissolved.UEIM Limited: The company did not trade and was dissolved.SDDS Capital Limited: The company has not traded and will be dissolved.

 

Mr. McDonald was a director of Navios Maritime Acquisition Corporation until October 2021. 

 

There are no further disclosures required under paragraph 9.6.13R of the Listing Rules. This announcement has been made in accordance with Listing Rules 9.6.11 R and 9.6.13R. 

 

 

For further information, please contact:

Allied Minds plc

 

c/o Instinctif Partners

Bruce Failing

Instinctif Partners (Communications)

Tim Linacre / Rozi Morris / Joe Quinlan

alliedminds@instinctif.com

 

 

About Allied Minds

 

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFMRTMTMTBTT
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.